Tuberculosis

Tuberculosis: Trial of multidrug-resistant TB treatment ends enrolment early after independent board indicates new regimen is superior
Step UP For TB: Report shows new tests and drugs for world’s deadliest infectious disease remain out of reach
Hamari Awaaz: Addressing stigma in people living with multidrug-resistant tuberculosis in India
endTB trial: First patient enrolls for clinical trials of novel, short and all-oral regimens for multidrug-resistant tuberculosis in India
Tuberculosis: MSF welcomes WHO revision in TB guidelines and urges greater access and affordability in India to new regimen
Access to medicines: Governments must scale up better TB treatment as J&J drops crucial drug price
Mumbai: As the COVID-19 pandemic rages on, “I hope my treatment can continue and I can be cured.”
World Tuberculosis Day: “It’s time” to end the suffering and accelerate access to all oral regimen
COVID-19: Avoiding a ‘second tragedy’ for those with TB
Access to medicines: As J&J release earnings, MSF protests price of lifesaving TB drug